4TH ANNUAL CELL CULTURE and BIOPROCESSING CONGRESS
The Royal College of Surgeons of England *LONDON , UK Visit the Venue to read more
Over 170 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
50 presentations, case studies and panel discussions focused on the key issues in cell line optimisation, process development and biological production
4 interactive streams:
Cell Line Development: Stem Cells, Genome-Editing, CRISPR & NGS
Cell Line Development: Mammalian & Bacterial Expression Systems
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
Oxford Global are proud to present the 4th Annual Cell Culture & Bioprocessing Congress, taking place on the 9th & 10th November 2015 in London.
This Congress is an executive platform for over 170 experts to network, exchange ideas, and discuss the latest innovations in the field. Delegates come from a variety of areas, including cell line development, cell line engineering, up and downstream operations, biotechnology, process development, biologics production and more.
The value of the cell culture industry is experiencing extraordinary growth, with a projected value of around $24 billion by 2018. Our Congress will bring together leading minds in the field to discuss ways to address industry challenges and growth. Supporting this exchange will be key solution providers; in 2014 these included Merck Millipore, Eppendorf, Solentim, ProteoNic and Irvine Scientific. Providing a comprehensive round up of the latest in cell culture and biological processing, the conference will cover subjects spanning from raw materials quality control and novel cell line development technologies, to advances in process development and strategies to deal with moving to clinical trial and manufacture.
On Day One, the conference will address stem cell development, gene-editing, cell genome NGS sequencing and CRISPR technology. Our expert speakers will discuss technologies for precise genome editing as well as the potential uses gene editing could have in future, how to ensure quality of raw materials in stem cell culture, and 3D cell culture technologies. Key issues to be covered in our Process Development stream include novel single use technologies, analytics development and the processing of Bispecific antibodies.
Day two of the event will see our leading industry and academic speakers present subjects such as the optimisation of cell lines, contamination issues in manufacture, efficient technology transfer, strategies in the use of Quality by Design, and the future of continuous processing. Other key topics that delegates will have the opportunity to hear about include first hand experiences from speakers of biosimilar cell line development, and innovation in the early development of bispecific antibodies. Our cell line development stream will have a focus on innovation in the use of both mammalian and bacterial expression systems.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
The Royal College of Surgeons of England
Royal College of Surgeons
35-43 Lincoln’s Inn Fields
Tel: +44 (0) 20 7405 3474